|国家科技期刊平台
首页|期刊导航|中国药业|1例口服雄黄制剂致白血病患儿急性砷中毒死亡原因分析

1例口服雄黄制剂致白血病患儿急性砷中毒死亡原因分析OACSTPCD

Lethal Cause of Acute Arsenic Poisoning Caused by Oral Realgar Preparations in the Treatment of a Child with Leukemia:A Case Report

中文摘要英文摘要

目的 探讨雄黄制剂致急性砷中毒的原因.方法 回顾性分析 1 例口服雄黄制剂致白血病患儿急性砷中毒的诊治过程,总结雄黄制剂治疗儿童白血病的砷中毒特点及治疗注意事项.结果 患儿雄黄日用量为 1g,远高于单味日用量 50~100 mg;临床症状为多器官功能衰竭,尿砷含量为 33.56µmol/L,远超过人体尿砷正常值 1.8µmol/L,诊断为急性砷中毒.结论 该患儿雄黄日用量属超剂量用药.雄黄制剂的剂量和疗程应符合药品说明书要求,不可长期和超量服用,一旦出现心律失常和心电图QT间期延长等砷中毒症状时应立即停药,保证用药安全.

Objective To investigate the cause of acute arsenic poisoning caused by realgar preparations.Methods A retrospective analysis was conducted on the diagnosis and treatment of acute arsenic poisoning caused by oral realgar preparations in a child with leukemia.The characteristics of arsenic poisoning in the child with leukemia treated with realgar preparations and the treatment precautions were summarized.Results The daily dosage of realgar in the child was 1 g,which was much higher than the daily dosage of a single ingredient of 50-100 mg.The clinical symptom was multiple organ failure,with a urine arsenic content of 33.56 µmol/L,far exceeding the normal value of human urine arsenic(1.8 µmol/L),and the child was diagnosed as acute arsenic poisoning.Conclusion The daily dosage of realgar for the child belongs to overdose medication.The dosage and course of treatment of realgar preparations should meet the requirements of the drug package insert,and should not be taken for a long time or overdose.Once arsenic poisoning symptoms such as arrhythmia and prolonged QT interval on electrocardiogram occur,the medication should be stopped immediately to ensure the medication safety of the patient.

彭军;张丽荣;杨光;凌云

河北燕达医院,河北 廊坊 065201

药学

雄黄儿童白血病急性砷中毒致死原因

realgarchildhood leukemiaacute arsenic poisoninglethal cause

《中国药业》 2024 (001)

122-124 / 3

10.3969/j.issn.1006-4931.2024.01.027

评论